Chanticleer Holdings Price to Book Ratio 2006-2020 | SONN

Historical price to book ratio values for Chanticleer Holdings (SONN) over the last 10 years. The current price to book ratio for Chanticleer Holdings as of November 26, 2020 is 62.71.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chanticleer Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-11-25 2.58 62.47
2020-06-30 3.64 $0.04 88.14
2020-03-31 271.14 $-5.38 -50.41
2019-12-31 398.84 $-7.88 -50.64
2019-09-30 489.43 $-0.51 -954.23
2019-06-30 743.60 $25.64 29.00
2019-03-31 1169.48 $48.46 24.13
2018-12-31 872.04 $57.73 15.10
2018-09-30 1676.48 $64.23 26.10
2018-06-30 2088.84 $73.99 28.23
2018-03-31 2501.21 $73.16 34.19
2017-12-31 1777.82 $97.97 18.15
2017-09-30 1766.39 $129.50 13.64
2017-06-30 2109.12 $152.02 13.87
2017-03-31 2433.60 $152.37 15.97
2016-12-31 2839.21 $166.42 17.06
2016-09-30 3717.33 $182.54 20.36
2016-06-30 2906.81 $182.91 15.89
2016-03-31 5475.61 $247.96 22.08
2015-12-31 6755.96 $264.85 25.51
2015-09-30 7436.01 $294.93 25.21
2015-06-30 16697.23 $410.35 40.69
2015-03-31 16156.43 $457.15 35.34
2014-12-31 11659.00 $536.48 21.73
2014-09-30 13993.23 $761.64 18.37
2014-06-30 17718.00 $621.89 28.49
2014-03-31 25417.65 $619.10 41.06
2013-12-31 36301.27 $541.80 67.00
2013-09-30 32988.19 $535.12 61.65
2013-06-30 20280.04 $290.57 69.79
2013-03-31 12708.83 0.00
2012-12-31 24606.45 $388.21 63.38
2012-09-30 24606.45 0.00
2012-06-30 29675.78 0.00
2012-03-31 43940.09 0.00
2011-12-31 50024.10 $99.82 501.14
2011-09-30 43940.09 0.00
2011-06-30 40424.88 0.00
2011-03-31 43264.09 0.00
2010-12-31 28730.06 0.00
2010-09-30 27040.05 0.00
2010-06-30 27040.05 0.00
2010-03-31 28730.06 0.00
2009-12-31 27040.05 0.00
2009-09-30 26972.45 0.00
2009-06-30 36504.07 0.00
2009-03-31 30420.06 0.00
2008-12-31 38870.08 0.00
2008-09-30 47320.09 0.00
2008-06-30 47320.09 0.00
2008-03-31 43940.09 0.00
2007-12-31 35152.07 0.00
2007-09-30 66924.13 0.00
2007-06-30 54080.11 0.00
2007-03-31 67600.14 0.00
2006-12-31 74360.15 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.030B
Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.047B 10.20
Amgen (AMGN) United States $128.345B 13.42
CSL (CSLLY) Australia $107.136B 0.00
Gilead Sciences (GILD) United States $75.525B 10.04
Vertex Pharmaceuticals (VRTX) United States $56.298B 26.18
Regeneron Pharmaceuticals (REGN) United States $54.004B 19.16
Illumina (ILMN) United States $44.622B 61.37
Moderna (MRNA) United States $39.001B 0.00
Biogen (BIIB) United States $37.318B 6.63
Seagen (SGEN) United States $29.684B 78.39
Alexion Pharmaceuticals (ALXN) United States $26.942B 10.73
BeiGene (BGNE) Cayman Islands $23.260B 0.00
Genmab (GMAB) Denmark $23.092B 27.31
BioNTech SE (BNTX) Germany $23.049B 0.00
Genmab (GNMSF) Denmark $21.857B 5.03
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.682B 0.00
Exact Sciences (EXAS) United States $17.639B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.572B 59.05
Horizon Therapeutics Public (HZNP) Ireland $15.238B 21.78
Alnylam Pharmaceuticals (ALNY) United States $14.599B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.152B 93.93
ARGENX SE-ADR (ARGX) Netherlands $12.329B 0.00
Bio-Techne Corp (TECH) United States $11.692B 74.77
Guardant Health (GH) United States $11.297B 0.00
Mirati Therapeutics (MRTX) United States $11.233B 0.00
Sarepta Therapeutics (SRPT) United States $10.662B 0.00
QIAGEN (QGEN) Netherlands $10.604B 23.88
Repligen (RGEN) United States $9.427B 133.69
ACADIA Pharmaceuticals (ACAD) United States $8.699B 0.00
Ascendis Pharma (ASND) Denmark $8.508B 0.00
Galapagos (GLPG) Belgium $8.072B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.771B 0.00
Denali Therapeutics (DNLI) United States $7.317B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.257B 0.00
Acceleron Pharma (XLRN) United States $6.874B 0.00
Adaptive Biotechnologies (ADPT) United States $6.156B 0.00
Novavax (NVAX) United States $6.069B 0.00
Amicus Therapeutics (FOLD) United States $5.871B 0.00
Blueprint Medicines (BPMC) United States $5.759B 19.07
Exelixis (EXEL) United States $5.715B 38.38
Reata Pharmaceuticals (RETA) United States $5.572B 0.00
Halozyme Therapeutics (HALO) United States $5.501B 254.31
SWEDISH ORP BIO (BIOVF) Sweden $5.271B 14.40
NeoGenomics (NEO) United States $5.009B 1503.67
Fate Therapeutics (FATE) United States $4.822B 0.00
China Biologic Products (CBPO) China $4.673B 30.29
Twist Bioscience (TWST) United States $4.653B 0.00
Emergent Biosolutions (EBS) United States $4.196B 13.77
Insmed (INSM) United States $4.049B 0.00
Arena Pharmaceuticals (ARNA) United States $3.803B 0.00
Legend Biotech (LEGN) United States $3.637B 0.00
MorphoSys AG (MOR) Germany $3.531B 127.81
Deciphera Pharmaceuticals (DCPH) United States $3.516B 0.00
Vir Biotechnology (VIR) United States $3.465B 0.00
Eidos Therapeutics (EIDX) United States $3.326B 0.00
Alkermes (ALKS) Ireland $2.924B 28.70
Bluebird Bio (BLUE) United States $2.830B 0.00
Seres Therapeutics (MCRB) United States $2.800B 0.00
Global Blood Therapeutics (GBT) United States $2.692B 0.00
Beam Therapeutics (BEAM) United States $2.409B 0.00
Zymeworks (ZYME) Canada $2.189B 0.00
I-Mab (IMAB) China $2.120B 0.00
UniQure (QURE) Netherlands $2.067B 0.00
Intellia Therapeutics (NTLA) United States $2.057B 0.00
Intra-Cellular Therapies (ITCI) United States $2.045B 0.00
Viela Bio (VIE) United States $1.997B 0.00
Mesoblast (MESO) Australia $1.964B 0.00
PHARMA MAR SA (PHMMF) Spain $1.921B 0.00
Editas Medicine (EDIT) United States $1.809B 0.00
Sorrento Therapeutics (SRNE) United States $1.783B 0.00
Amarin (AMRN) Ireland $1.752B 0.00
Mersana Therapeutics (MRSN) United States $1.747B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.723B 0.00
Inovio Pharmaceuticals (INO) United States $1.720B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.650B 0.00
Arcus Biosciences (RCUS) United States $1.647B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Revance Therapeutics (RVNC) United States $1.558B 0.00
NGM Biopharmaceuticals (NGM) United States $1.551B 0.00
Alcobra (ARCT) United States $1.473B 0.00
Scholar Rock Holding (SRRK) United States $1.436B 0.00
Zealand Pharma (ZEAL) Denmark $1.425B 0.00
Sangamo Therapeutics (SGMO) United States $1.410B 0.00
Myriad Genetics (MYGN) United States $1.403B 0.00
Ligand Pharmaceuticals (LGND) United States $1.391B 36.05
Adverum Biotechnologies (ADVM) United States $1.385B 0.00
Coherus BioSciences (CHRS) United States $1.347B 8.90
REGENXBIO (RGNX) United States $1.344B 0.00
Athenex (ATNX) United States $1.296B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Heska (HSKA) United States $1.219B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.201B 0.00
Epizyme (EPZM) United States $1.199B 0.00
Travere Therapeutics (TVTX) United States $1.192B 0.00
Cytokineticsorporated (CYTK) United States $1.167B 0.00
Precigen (PGEN) United States $1.128B 0.00
Genetron Holdings (GTH) China $1.081B 0.00
Codexis (CDXS) United States $1.061B 0.00
Vericel (VCEL) United States $1.053B 0.00
Alector (ALEC) United States $1.048B 0.00
Pliant Therapeutics (PLRX) United States $1.044B 0.00
Northwest Biotherapeutics (NWBO) United States $1.022B 0.00
Morphic Holding (MORF) United States $0.975B 0.00
Arvinas (ARVN) United States $0.967B 0.00
Cellectis S.A (CLLS) France $0.958B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.907B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.903B 0.00
Castle Biosciences (CSTL) United States $0.894B 0.00
Celldex Therapeutics (CLDX) United States $0.880B 0.00
Frequency Therapeutics (FREQ) United States $0.876B 0.00
Protagonist Therapeutics (PTGX) United States $0.850B 0.00
Compugen (CGEN) Israel $0.835B 0.00
NantKwest (NK) United States $0.824B 0.00
Cara Therapeutics (CARA) United States $0.755B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 17.19
MiMedx (MDXG) United States $0.722B 0.00
MannKind (MNKD) United States $0.712B 0.00
Five Prime Therapeutics (FPRX) United States $0.702B 0.00
Agenus (AGEN) United States $0.694B 0.00
Cardiff Oncology (CRDF) United States $0.691B 0.00
Kadmon Holdings (KDMN) United States $0.686B 0.00
Albireo Pharma (ALBO) United States $0.682B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.678B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.675B 34.28
AnaptysBio (ANAB) United States $0.674B 0.00
Sutro Biopharma (STRO) United States $0.657B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
ZIOPHARM Oncology Inc (ZIOP) United States $0.619B 0.00
Precision BioSciences (DTIL) United States $0.616B 0.00
VBI Vaccines (VBIV) United States $0.603B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.569B 0.00
Geron (GERN) United States $0.562B 0.00
Anika Therapeutics (ANIK) United States $0.555B 75.08
IVERIC Bio (ISEE) United States $0.554B 0.00
Avid Bioservices (CDMO) United States $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.508B 0.00
MeiraGTx Holdings (MGTX) United States $0.497B 0.00
Forte Biosciences (FBRX) United States $0.476B 0.00
Cel-Sci (CVM) United States $0.474B 0.00
Merus (MRUS) Netherlands $0.467B 0.00
Dynavax Technologies (DVAX) United States $0.457B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.456B 0.00
Amryt Pharma (AMYT) United Kingdom $0.445B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.443B 0.00
WAVE Life Sciences (WVE) Singapore $0.439B 0.00
Puma Biotechnology (PBYI) United States $0.433B 0.00
UROGEN PHARMA (URGN) United States $0.433B 0.00
Spero Therapeutics (SPRO) United States $0.432B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.419B 0.00
Starpharma Holdings (SPHRY) Australia $0.408B 0.00
Innate Pharma S.A (IPHA) France $0.408B 0.00
Kala Pharmaceuticals (KALA) United States $0.403B 0.00
Affimed (AFMD) Germany $0.391B 0.00
Clovis Oncology (CLVS) United States $0.388B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
AC Immune SA (ACIU) Switzerland $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.375B 17.67
Cue Biopharma (CUE) United States $0.375B 0.00
Trevena (TRVN) United States $0.372B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.361B 0.00
ANI Pharmaceuticals (ANIP) United States $0.361B 9.18
Syros Pharmaceuticals (SYRS) United States $0.360B 0.00
Cellular Biomedicine (CBMG) United States $0.359B 0.00
XOMA (XOMA) United States $0.358B 0.00
Selecta Biosciences (SELB) United States $0.351B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Athersys (ATHX) United States $0.312B 0.00
Arbutus Biopharma (ABUS) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.302B 0.00
Kamada (KMDA) Israel $0.297B 13.92
PDL BioPharma (PDLI) United States $0.286B 0.00
NextCure (NXTC) United States $0.280B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.278B 0.00
Verastem (VSTM) United States $0.268B 0.00
IBio (IBIO) United States $0.268B 0.00
DBV Technologies S.A (DBVT) France $0.264B 0.00
CorMedix Inc (CRMD) United States $0.255B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
TELA Bio (TELA) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.236B 0.00
Pluristem Therapeutics (PSTI) Israel $0.234B 0.00
Aptinyx (APTX) United States $0.209B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.192B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
GENFIT S.A (GNFT) France $0.185B 0.00
Theratechnologies (THTX) Canada $0.185B 0.00
Aptevo Therapeutics (APVO) United States $0.182B 0.00
AquaBounty Technologies (AQB) United States $0.179B 0.00
Bellus Health (BLU) Canada $0.178B 0.00
Cerecor (CERC) United States $0.178B 0.00
Eton Pharmaceuticals (ETON) United States $0.176B 0.00
ADMA Biologics Inc (ADMA) United States $0.175B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Checkpoint Therapeutics (CKPT) United States $0.164B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.164B 0.00
VolitionRX (VNRX) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.162B 0.00
Biofrontera AG (BFRA) Germany $0.160B 0.00
Dyadic (DYAI) United States $0.159B 0.00
Oncobiologics (OTLK) United States $0.158B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
SESEN BIO, INC (SESN) United States $0.147B 0.00
Idera Pharmaceuticals (IDRA) United States $0.137B 0.00
VTv Therapeutics (VTVT) United States $0.137B 0.00
Abeona Therapeutics (ABEO) United States $0.137B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
Protalix BioTherapeutics (PLX) Israel $0.133B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Exicure (XCUR) United States $0.122B 0.00
Orgenesis (ORGS) United States $0.118B 245.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Antibe Therapeutics (ATBPF) Canada $0.117B 0.00
TRACON Pharmaceuticals (TCON) United States $0.116B 0.00
Gritstone Oncology (GRTS) United States $0.113B 0.00
Aytu Bioscience (AYTU) United States $0.112B 0.00
Applied Genetic Technologies (AGTC) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Cogent Biosciences (COGT) United States $0.107B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.105B 0.00
Cidara Therapeutics (CDTX) United States $0.102B 0.00
Cyclerion Therapeutics (CYCN) United States $0.101B 0.00
Novogen (KZIA) Australia $0.098B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Palatin Technologies (PTN) United States $0.095B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
Prometic Life Sciences (LMNL) Canada $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.092B 0.00
Cocrystal Pharma (COCP) United States $0.089B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
Curis (CRIS) United States $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 33.00
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.062B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
Organovo Holdings (ONVO) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Edesa Biotech (EDSA) Canada $0.050B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.049B 0.00
Seelos Therapeutics (SEEL) United States $0.046B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Genetic Technologies (GENE) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Titan Pharmaceuticals (TTNP) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
MedAvail Holdings (MDVL) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00